HWAM
NBIX icon

Hennion & Walsh Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Hennion & Walsh Asset Management’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$989K Sell
5,869
-55
-0.9% -$8.16K 0.03% 564
2026
Q1 		$780K Sell
5,924
-66
-1% -$8.76K 0.03% 570
2025
Q4 		$850K Sell
5,990
-143
-2% -$20.7K 0.03% 562
2025
Q3 		$861K Sell
6,133
-28
-0.5% -$3.79K 0.03% 548
2025
Q2 		$774K Sell
6,161
-146
-2% -$16.7K 0.03% 555
2025
Q1 		$698K Buy
6,307
+1,140
+22% +$144K 0.03% 559
2024
Q4 		$705K Sell
5,167
-4,413
-46% -$546K 0.03% 551
2024
Q3 		$1.1M Buy
9,580
+2,832
+42% +$388K 0.05% 429
2024
Q2 		$929K Sell
6,748
-57
-0.8% -$7.82K 0.05% 442
2024
Q1 		$939K Buy
6,805
+853
+14% +$116K 0.05% 435
2023
Q4 		$784K Sell
5,952
-83
-1% -$9.55K 0.04% 466
2023
Q3 		$679K Buy
6,035
+435
+8% +$45.8K 0.04% 445
2023
Q2 		$528K Buy
5,600
+113
+2% +$11K 0.03% 494
2023
Q1 		$555K Buy
5,487
+933
+20% +$97.1K 0.03% 488
2022
Q4 		$544K Buy
+4,554
New +$533K 0.03% 484
2021
Q2 		– Sell
-12,719
Closed -$1.24M – 741
2021
Q1 		$1.24M Buy
+12,719
New +$1.33M 0.07% 315

Other funds holding NBIX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PBBUPS
PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Hennion & Walsh Asset Management's NBIX Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Neurocrine Biosciences (NBIX) stake by 0.93% in Q2 2026, selling an estimated $8.16K and leaving 5,869 shares worth $989K. The position accounts for 0.03% of the portfolio, ranked #564.

Hennion & Walsh Asset Management first reported a position in NBIX in Q1 2021 and has held it in 16 quarters since. The position peaked at $1.24M in Q1 2021. 166 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Hennion & Walsh Asset Management held 5,869 shares of Neurocrine Biosciences worth $989K as of Q2 2026.
  • Hennion & Walsh Asset Management sold 55 Neurocrine Biosciences shares in Q2 2026, an estimated $8.16K.
  • Neurocrine Biosciences made up 0.03% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #564 holding.
  • Hennion & Walsh Asset Management first reported a position in Neurocrine Biosciences in Q1 2021 and has held it in 16 quarters since.
  • Hennion & Walsh Asset Management's Neurocrine Biosciences position peaked at $1.24M in Q1 2021.
  • 166 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.